We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Glucagon-producing Cells Forced to Produce Insulin: New Therapeutic Approach for Diabetes?
News

Alpha Cells Can be Forced to Compensate for Bad Neighbours in Diabetes

Glucagon-producing Cells Forced to Produce Insulin: New Therapeutic Approach for Diabetes?
News

Alpha Cells Can be Forced to Compensate for Bad Neighbours in Diabetes

Flexible cells: Ordinary cells are not static and predetermined, as was earlier believed. They can change identity and function. This discovery may provide an approach for new types of treatments in the future. Image credit: Luiza Ghila
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Glucagon-producing Cells Forced to Produce Insulin: New Therapeutic Approach for Diabetes?"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Diabetes is caused by damaged or non-existing insulin cells inability to produce insulin, a hormone that is necessary in regulating blood sugar levels. Many diabetes patients take insulin supplements to regulate these levels.

In collaboration with other international researchers, researchers at the University of Bergen have, discovered that glucagon producing cells in the pancreas, can change identity and adapt so that they do the job for their neighbouring damaged or missing insulin cells.

“We are possibly facing the start of a totally new form of treatment for diabetes, where the body can produce its own insulin, with some start-up help,” says Researcher Luiza Ghila at the Raeder Research Lab, Department of Clinical Science, University of Bergen (UiB).

The results are published in Nature Cell Biology.

The researchers discovered that only about 2 per cent of the neighbouring cells in the pancreas could change identity. However, event that amount makes the researchers are optimistic about potential new treatment approaches.

For the first time in history, researchers were able to describe the mechanisms behind the process of cell identity. It turns out that this is not at passive process, but is a result of signals from the surrounding cells. In the study, researchers were able to increase the number of insulin producing cells to 5 per cent, by using a drug that influenced the inter-cell signalling process. Thus far, the results have only been shown in animal models.

“If we gain more knowledge about the mechanisms behind this cell flexibility, then we could possibly be able to control the process and change more cells’ identities so that more insulin can be produced, ” Ghila explains.

Possible new treatment against cell death

According to the researchers, the new discoveries is good news - not only for diabetes treatment.

“The cells´ ability to change identity and function, may be a decisive discovery in treating other diseases caused by cell death, such as Alzheimer´s disease and cellular damage due to heart attacks”, says Luiza Ghila.

Additional info:

  • There are three different types of cells in the pancreas: alpha-cells, beta-cells and delta-cells. These produce different kinds of hormones for blood sugar regulation.
  • The cells make clusters. Alpha-cells produce glucagon, which increases the blood sugar levels. Beta-cells produce insulin, which decreases glucagon levels. Delta-cells produce somatostatin, which controls the regulation of the Alpha and Beta Cells.
  • Persons with diabetes have a damaged beta-cell function, and therefore have constant high blood sugar levels.

This article has been republished from materials provided by the University of Bergen. Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference:

Cigliola, V., Ghila, L., Thorel, F., Gurp, L. V., Baronnier, D., Oropeza, D., . . . Herrera, P. L. (2018). Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon α-cells. Nature Cell Biology, 20(11), 1267-1277. doi:10.1038/s41556-018-0216-y

Advertisement